IHH says Fortis acquisition delays caused losses amid Daiichi Sankyo dispute with debtorsIHH表示，由于第一三共与债务人发生纠纷，Fortis收购案的延误导致了损失。
KUALA LUMPUR: IHH Healthcare Bhd said it suffered losses due to delays in obtaining the required mandatory tender offer (MTO) approvals for its acquisition of Fortis Healthcare amid a dispute between Japanese pharmaceutical company Daiichi Sankyo Co Ltd and its "judgment debtors."
KUALA LUMPUR: IHH Healthcare Bhd said it suffered losses due to delays in obtaining the required mandatory tender offer (MTO) approvals for its acquisition of Fortis Healthcare amid a dispute between Japanese pharmaceutical company Daiichi Sankyo Co Ltd and its "judgment debtors.”
IHH said it was an unrelated party to the dispute and maintained that its acquisition of Fortis in 2018 was conducted through a transparent, widely publicised and fully regulated process.
Thank you for your report!
Corporate Malaysia beats the war blues
Robust 2Q keeps corporate growth on track
IHH says Fortis acquisition delays caused losses amid Daiichi Sankyo dispute with debtors
吉隆坡：IHH Healthcare Bhd 表示，由于日本制药公司第一三共株式会社与其“判决债务人”之间的纠纷，导致其收购 Fortis Healthcare 所需的强制性要约收购 (MTO) 批准延迟，因此遭受了损失。
IHH表示，它与这场纠纷无关，并坚称其在2018年收购Fortis的过程是透明的、广为宣传的、完全受监管的。
感谢您的报告！
马来西亚企业战胜了战争阴霾
强劲的第二季度业绩使公司增长保持正轨
IHH表示，由于第一三共与债务人发生纠纷，Fortis收购案的延误导致了损失。